USPTO serial 90251984
DREAMPREP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 8, 2022
- Examiner
- KLEINMAN, CORINNE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DREAMPREP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leo M. Loughlin
Leo M. Loughlin ROTHWELL FIGG ERNST & MANBECK P.C.901 New York Avenue, NWSuite 900 EastWashington, DC 20001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for scientific or research purposes, in particular for use in genomic research; Reagents for the derivatization of bio-molecules for scientific or research purposes, in particular for use related to mass spectroscopy; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use in laboratory or research clinical nucleic acid-based diagnostics; Reagents for the derivatization of bio-molecules for clinical-diagnostic laboratory or research use, in particular for use related to mass spectroscopy | ACTIVE | — |
| 005 | Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics; Reagents for the derivatization of bio-molecules for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to mass spectroscopy | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, absorption measuring devices, fluorescence measuring devices, pipetting devices and sampling devices for taking liquid samples; all the aforementioned products for laboratory use; Recorded and downloadable software for the automation of workflows related to genomic research and genome analysis; Recorded and downloadable software for the automation of workflows related to sequencing of nucleic acids; Recorded and downloadable software for the automation of workflows related to extraction, derivatization and concentration of biomolecules for mass spectroscopy; Analytical apparatus and instruments for clinical-diagnostic laboratory use, namely, absorption measuring apparatus, fluorescence measuring apparatus, pipetting apparatus and sampling devices for taking liquid samples; all the aforementioned products for clinical diagnostical laboratory purposes | ACTIVE | — |
| 010 | Analytical apparatus and instruments for clinical medical diagnostic use and veterinary diagnostic use, namely, absorption measuring apparatus, fluorescence measuring apparatus, pipetting apparatus and sampling devices for taking liquid samples; all the aforementioned products for clinical medical diagnostical purposes | ACTIVE | — |
| 042 | Providing on-line non-downloadable software for the automation of workflows related to genomic research and genome analysis; Providing on-line non-downloadable software for the automation of workflows related to sequencing of nucleic acids; Providing on-line non-downloadable software for the automation of workflows related to extraction, derivatization and concentration of bio-molecules for mass spectroscopy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tecan Trading AG
- Other trademarks owned by Tecan Trading AG
- Other trademarks owned by Tecan Trading AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named DREAMPREP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 19, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 19, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 19, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 8, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2020 | NWAP | NEW APPLICATION ENTERED | — |